12.08.22
Avgol has announced it will add a state-of-the-art, high speed Reicofil 5 line at its Mocksville, NC facility. It will be the company's sixth line at the site, which was first acquired in 2001.
"The addition of this new line enables us to have even greater production capacity, delivering component materials that are ‘Made in America’ and offering more sustainable options for the growing North America market and around the world,” says Avgol CEO Tommi Bjornman. “This additional new line also enables the Mocksville facility to deliver additional meltblown nonwovens, ensuring we have extra capacity to meet market demand."
The investment will deliver biocomponent and corresponding high-loft capabilities, with the line producing materials for applications that meet the needs of upper tier products for hygiene customers.
"Serving the growing baby diaper, adult incontinence and feminine hygiene markets along with satisfying sustained demand for meltblown filtration and medical materials, this investment enables Avgol to deliver an improved degree of service across the entire domestic region while consolidating and strengthening our existing position,” Bjornman adds.
As part of the investment, Avgol, which is part of Indorama Ventures, is also introducing extra capacity for meltblown production, ensuring a continuous supply of this critical material for both the region and customers worldwide.
Avgol's most recent U.S. investment took place in 2015 when it added its fifth spunmelt line in North Carolina. The company also has operations in Russia, China, Israel and India.
"The addition of this new line enables us to have even greater production capacity, delivering component materials that are ‘Made in America’ and offering more sustainable options for the growing North America market and around the world,” says Avgol CEO Tommi Bjornman. “This additional new line also enables the Mocksville facility to deliver additional meltblown nonwovens, ensuring we have extra capacity to meet market demand."
The investment will deliver biocomponent and corresponding high-loft capabilities, with the line producing materials for applications that meet the needs of upper tier products for hygiene customers.
"Serving the growing baby diaper, adult incontinence and feminine hygiene markets along with satisfying sustained demand for meltblown filtration and medical materials, this investment enables Avgol to deliver an improved degree of service across the entire domestic region while consolidating and strengthening our existing position,” Bjornman adds.
As part of the investment, Avgol, which is part of Indorama Ventures, is also introducing extra capacity for meltblown production, ensuring a continuous supply of this critical material for both the region and customers worldwide.
Avgol's most recent U.S. investment took place in 2015 when it added its fifth spunmelt line in North Carolina. The company also has operations in Russia, China, Israel and India.
